Key result
Iodoacetamide and its fluorescent derivative IAEDANS specifically bind to the identical site (Cys 674) on the C-terminal half of sarcoplasmic reticulum Ca2+,Mg2+-ATPase.
Population
Sarcoplasmic reticulum (SR) membranes
Design
Preclinical
Authors
Loading...
Cys 674 labeling may enable SERCA studies in cardiac models; leaves open its functional or therapeutic relevance in humans.
The study identifies Cys 674 as the specific binding site for iodoacetamide and IAEDANS on the sarcoplasmic reticulum Ca2+,Mg2+-ATPase.
Yamashita et al. (1987) studied this question. Iodoacetamide (IAA) and IAEDANS was evaluated on Identification of specific binding site on sarcoplasmic reticulum Ca2+,Mg2+-ATPase. Iodoacetamide and its fluorescent derivative IAEDANS specifically bind to the identical site (Cys 674) on the C-terminal half of sarcoplasmic reticulum Ca2+,Mg2+-ATPase.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: